348 related articles for article (PubMed ID: 26850475)
1. Angiogenic factor with G patch and FHA domains 1 (Aggf1) regulates liver fibrosis by modulating TGF-β signaling.
Zhou B; Zeng S; Li L; Fan Z; Tian W; Li M; Xu H; Wu X; Fang M; Xu Y
Biochim Biophys Acta; 2016 Jun; 1862(6):1203-13. PubMed ID: 26850475
[TBL] [Abstract][Full Text] [Related]
2.
Yan J; Hu B; Shi W; Wang X; Shen J; Chen Y; Huang H; Jin L
Am J Physiol Gastrointest Liver Physiol; 2021 May; 320(5):G720-G728. PubMed ID: 33728992
[TBL] [Abstract][Full Text] [Related]
3. Coordinated signaling of activating transcription factor 6α and inositol-requiring enzyme 1α regulates hepatic stellate cell-mediated fibrogenesis in mice.
Xue F; Lu J; Buchl SC; Sun L; Shah VH; Malhi H; Maiers JL
Am J Physiol Gastrointest Liver Physiol; 2021 May; 320(5):G864-G879. PubMed ID: 33728997
[TBL] [Abstract][Full Text] [Related]
4. NLRC5 regulates TGF-β1-induced proliferation and activation of hepatic stellate cells during hepatic fibrosis.
Xu T; Ni MM; Xing-Li ; Li XF; Meng XM; Huang C; Li J
Int J Biochem Cell Biol; 2016 Jan; 70():92-104. PubMed ID: 26592197
[TBL] [Abstract][Full Text] [Related]
5. Myocardin-related transcription factor A (MRTF-A) plays an essential role in hepatic stellate cell activation by epigenetically modulating TGF-β signaling.
Tian W; Fan Z; Li J; Hao C; Li M; Xu H; Wu X; Zhou B; Zhang L; Fang M; Xu Y
Int J Biochem Cell Biol; 2016 Feb; 71():35-43. PubMed ID: 26693892
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis.
Lakner AM; Steuerwald NM; Walling TL; Ghosh S; Li T; McKillop IH; Russo MW; Bonkovsky HL; Schrum LW
Hepatology; 2012 Jul; 56(1):300-10. PubMed ID: 22278637
[TBL] [Abstract][Full Text] [Related]
7. The Role of Lipin-1 in the Regulation of Fibrogenesis and TGF-β Signaling in Hepatic Stellate Cells.
Jang CH; Kim KM; Yang JH; Cho SS; Kim SJ; Shin SM; Cho IJ; Ki SH
Toxicol Sci; 2016 Sep; 153(1):28-38. PubMed ID: 27345520
[TBL] [Abstract][Full Text] [Related]
8. Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells.
Du K; Hyun J; Premont RT; Choi SS; Michelotti GA; Swiderska-Syn M; Dalton GD; Thelen E; Rizi BS; Jung Y; Diehl AM
Gastroenterology; 2018 Apr; 154(5):1465-1479.e13. PubMed ID: 29305935
[TBL] [Abstract][Full Text] [Related]
9. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-30 Protects Against Carbon Tetrachloride-induced Liver Fibrosis by Attenuating Transforming Growth Factor Beta Signaling in Hepatic Stellate Cells.
Tu X; Zheng X; Li H; Cao Z; Chang H; Luan S; Zhu J; Chen J; Zang Y; Zhang J
Toxicol Sci; 2015 Jul; 146(1):157-69. PubMed ID: 25912033
[TBL] [Abstract][Full Text] [Related]
11. Methylation of RCAN1.4 mediated by DNMT1 and DNMT3b enhances hepatic stellate cell activation and liver fibrogenesis through Calcineurin/NFAT3 signaling.
Pan XY; You HM; Wang L; Bi YH; Yang Y; Meng HW; Meng XM; Ma TT; Huang C; Li J
Theranostics; 2019; 9(15):4308-4323. PubMed ID: 31285763
[No Abstract] [Full Text] [Related]
12. Enhancer of Zeste Homologue 2 Inhibition Attenuates TGF-β Dependent Hepatic Stellate Cell Activation and Liver Fibrosis.
Martin-Mateos R; De Assuncao TM; Arab JP; Jalan-Sakrikar N; Yaqoob U; Greuter T; Verma VK; Mathison AJ; Cao S; Lomberk G; Mathurin P; Urrutia R; Huebert RC; Shah VH
Cell Mol Gastroenterol Hepatol; 2019; 7(1):197-209. PubMed ID: 30539787
[TBL] [Abstract][Full Text] [Related]
13. Proline-rich tyrosine kinase 2 mediates transforming growth factor-beta-induced hepatic stellate cell activation and liver fibrosis.
Kim J; Kang W; Kang SH; Park SH; Kim JY; Yang S; Ha SY; Paik YH
Sci Rep; 2020 Dec; 10(1):21018. PubMed ID: 33273492
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional repression of SIRT1 by protein inhibitor of activated STAT 4 (PIAS4) in hepatic stellate cells contributes to liver fibrosis.
Sun L; Fan Z; Chen J; Tian W; Li M; Xu H; Wu X; Shao J; Bian Y; Fang M; Xu Y
Sci Rep; 2016 Jun; 6():28432. PubMed ID: 27323886
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-212 activates hepatic stellate cells and promotes liver fibrosis via targeting SMAD7.
Zhu J; Zhang Z; Zhang Y; Li W; Zheng W; Yu J; Wang B; Chen L; Zhuo Q; Chen L; Zhang J; Liu J
Biochem Biophys Res Commun; 2018 Jan; 496(1):176-183. PubMed ID: 29307832
[TBL] [Abstract][Full Text] [Related]
16. Rev-erb agonist and TGF-β similarly affect autophagy but differentially regulate hepatic stellate cell fibrogenic phenotype.
Thomes PG; Brandon-Warner E; Li T; Donohue TM; Schrum LW
Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):137-147. PubMed ID: 27840152
[TBL] [Abstract][Full Text] [Related]
17. Effect of SEPT6 on the biological behavior of hepatic stellate cells and liver fibrosis in rats and its mechanism.
Fan Y; Du Z; Steib CJ; Ding Q; Lu P; Tian D; Liu M
Lab Invest; 2019 Jan; 99(1):17-36. PubMed ID: 30315255
[TBL] [Abstract][Full Text] [Related]
18. Isorhamnetin attenuates liver fibrosis by inhibiting TGF-β/Smad signaling and relieving oxidative stress.
Yang JH; Kim SC; Kim KM; Jang CH; Cho SS; Kim SJ; Ku SK; Cho IJ; Ki SH
Eur J Pharmacol; 2016 Jul; 783():92-102. PubMed ID: 27151496
[TBL] [Abstract][Full Text] [Related]
19. Endoglin in human liver disease and murine models of liver fibrosis-A protective factor against liver fibrosis.
Alsamman M; Sterzer V; Meurer SK; Sahin H; Schaeper U; Kuscuoglu D; Strnad P; Weiskirchen R; Trautwein C; Scholten D
Liver Int; 2018 May; 38(5):858-867. PubMed ID: 28941022
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional factor ATF3 promotes liver fibrosis via activating hepatic stellate cells.
Shi Z; Zhang K; Chen T; Zhang Y; Du X; Zhao Y; Shao S; Zheng L; Han T; Hong W
Cell Death Dis; 2020 Dec; 11(12):1066. PubMed ID: 33311456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
